Ablation heart procedure reduces risk of Alzheimer and stroke

Cardiac procedure significantly reduces risk of Alzheimer’s disease and stroke, researchers find – Researchers found that ablation treatment can eliminate serious risks associated with atrial fibrillation. New research was presented at National Heart Rhythm Society.

Safety concern for HIV drug combination

FDA Announces Possible Safety Concern for HIV Drug Combination – The U.S. Food and Drug Administration announced preliminary data suggesting that Invirase (saquinavir) in combination with Norvir (ritonavir) may have potentially important adverse effects on the heart.

Catheter treatment works better than drugs for heart rhythm disorder

Landmark heart treatment study — Atrial fibrillation treatment with catheter shows better results than drug therapy – Treating a common heart rhythm disorder by burning heart tissue with a catheter works dramatically better than drug treatments, according to a landmark study published in the Jan. 27 issue of the Journal of the American Medical Association (JAMA).

Public smoking bans reduce heart attacks

Banning smoking in public places and workplaces is good for the heart — Inhaling secondhand smoke greatly increases risk of heart attack, even among young and nonsmokers. – Public smoking bans appear to significantly reduce the risk of heart attacks, particularly among younger individuals and nonsmokers, revealed by researchers in a new study.

Anticoagulant Dabigatran effective in atrial fibrillation patients

Dabigatran vs. warfarin as long-term anticoagulant therapy in atrial fibrillation – The anticoagulant dabigatran is more effective than warfarin in the prevention of stroke in patients with atrial fibrillation, revealed by researchers in a study RE-LY (Randomized Evaluation of Long-term anticoagulant therapY).

Sanofi’s Multaq approved to treat heart rhythm disorder, US

U.S. Food and Drug Administration (FDA) Approves Sanofi’s Multaq dronedarone to Treat Heart Rhythm Disorders – The U.S. Food and Drug Administration has approved Sanofi’s Multaq tablets (dronedarone) to help maintain normal heart rhythms in patients with a history of atrial fibrillation or atrial flutter (heart rhythm disorders or arrhythmia).

New CRT therapy prevents heart failure

New therapy found to prevent heart failure – Implanted cardiac resynchronization therapy device with defibrillator (CRT-D) reduced a 29 percent reduction in heart failure or death in patients with heart disease, revealed by researchers.

Women with chest pain get no proper treatment from paramedics

Women with chest pain less likely then men to get proper treatment from paramedics – Penn study shows gender disparities in pre-hospital care. – Women with chest pain are less likely than male patients to receive recommended, proven therapies while en route to the hospital, according to new research from the University of Pennsylvania School of Medicine.

Heart disorder linked to Alzheimer’s disease dementia

Heart disorder atrial fibrillation linked to Alzheimer’s disease dementia. Study of more than 37,000 patients shows relationship between atrial fibrillation and development of Alzheimer’s disease. – Researchers at Intermountain Medical Center in Salt Lake City believe that they have made a breakthrough connection between atrial fibrillation, a fairly common heart rhythm disorder, and Alzheimer’s disease, the leading form of dementia among Americans.

ICD success depends on physician certification

Type of physician certification associated with risk of complications from ICDs – Patients whose implantable cardioverter-defibrillators (ICDs) are implanted by nonelectrophysiologists are at increased risk of complications and are less likely to receive a specific type of ICD when clinically indicated, according to a study in the April 22/29 issue of JAMA.

Health Newstrack